Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test.
Transitioned all 6 CTS labs from an investigational new drug (IND) to a licensed Zika test, and anno...
As a component of the CTS Business Continuity Plan, today all 6 labs began using the same laboratory...
By the end of 2017, CTS has secured three source plasma partners and continues to seek additional pa...
CTS Tampa lab implemented the Ortho Clinical Diagnostics VITROS® testing platform to perform COVID-1...
CTS Tampa lab implements Dengue testing on behalf of a healthcare partner in an endemic area.
CTS Research Consortium was established to further CTS’s leadership in infectious disease research....